Titular de la autorización de comercialización
Janssen Pharms
75 medicamentos en 1 país, como titular de la autorización.
Cargando…
Titular de la autorización de comercialización
75 medicamentos en 1 país, como titular de la autorización.
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos registrados a su nombre, primero los vigentes.
1–25 de 75
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| AXERT12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Almotriptan malate | Estados Unidos | No comercializado | 2001 |
| CONCERTA18mg | 27mg | 36mg | 54mg · Tablet, extended release | Methylphenidate | Estados Unidos | Comercializado | 2000 |
| DITROPAN5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Oxybutynin | Estados Unidos | No comercializado | 1975 |
| DITROPAN XL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Oxybutynin | Estados Unidos | No comercializado | 1998 |
| DURAGESIC-100100MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Film, extended release | Fentanyl | Estados Unidos | No comercializado | 1990 |
| DURAGESIC-1212.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Film, extended release | Fentanyl | Estados Unidos | No comercializado | 1990 |
| DURAGESIC-2525MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Film, extended release | Fentanyl | Estados Unidos | No comercializado | 1990 |
| DURAGESIC-3737.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Film, extended release | Fentanyl | Estados Unidos | No comercializado | 1990 |
| DURAGESIC-5050MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Film, extended release | Fentanyl | Estados Unidos | No comercializado | 1990 |
| DURAGESIC-7575MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Film, extended release | Fentanyl | Estados Unidos | No comercializado | 1990 |
| ELMIRON100mg · Capsule | Pentosan polysulfate sodium | Estados Unidos | Comercializado | 1996 |
| ERGAMISOL50mg base · Tablet | Levamisole | Estados Unidos | No comercializado | 1990 |
| FLOXIN200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ofloxacin | Estados Unidos | No comercializado | 1990 |
| HALDOL100mg base/ml | 50mg base/ml · Injectable | Haloperidol | Estados Unidos | No comercializado | 1986 |
| HALDOL5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Haloperidol | Estados Unidos | No comercializado | 1971 |
| IMODIUM1mg/5ml · Solution | Loperamide | Estados Unidos | No comercializado | 1984 |
| INVEGA1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 12MG | 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 3MG | 6MG | 9MG · Tablet, extended release | Paliperidone | Estados Unidos | Comercializado | 2006 |
| INVEGA HAFYERA1.092gm/3.5ml (312mg/ml) | 1.560gm/5ml (312mg/ml) · Suspension, extended release | Paliperidone | Estados Unidos | Comercializado | 2015 |
| INVEGA SUSTENNA117mg/0.75ml (117mg/0.75ml) | 156mg/ml (156mg/ml) | 234mg/1.5ml (156mg/ml) | 39mg/0.25ml (39mg/0.25ml) | 78mg/0.5ml (78mg/0.5ml) · Suspension, extended release | Paliperidone | Estados Unidos | Comercializado | 2009 |
| INVEGA TRINZA273mg/0.875ml (273mg/0.875ml) | 410mg/1.315ml (311.79mg/ml) | 546mg/1.75ml (312mg/ml) | 819mg/2.625ml (312mg/ml) · Suspension, extended release | Paliperidone | Estados Unidos | Comercializado | 2015 |
| INVOKAMET150mg; 1gm | 150mg; 500mg | 50mg; 1gm | 50mg; 500mg · Tablet | Canagliflozin, Metformin | Estados Unidos | Comercializado | 2014 |
| INVOKAMET XR150mg; 1gm | 150mg; 500mg | 50mg; 1gm | 50mg; 500mg · Tablet, extended release | Canagliflozin, Metformin | Estados Unidos | Comercializado | 2016 |
| INVOKANA100mg | 300mg · Tablet | Canagliflozin | Estados Unidos | Comercializado | 2013 |
| LEUSTATIN1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Cladribine | Estados Unidos | No comercializado | 1993 |
| LEVAQUIN250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Levofloxacin | Estados Unidos | No comercializado | 1996 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Estados Unidos | 75 | 75 | 0 | EmpresasTodos los medicamentos |
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Janssen Pharms en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaOtras empresas del mismo grupo.